Lot 1
No lot description published.
Buyer: NHS England →
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 Offer reference number: CM/PHS/25/5728 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/PHS/25/5728/01 - National Framework for Medical Retinal Vascular Treatments: 7NAT (National) 01/12/2025 to 31/05/2027 (18 months) CM/PHS/25/5728/02 - Regional Framework for Medical Retinal Vascular Treatments aflibercept 2mg: NOFE: (North of England) 01/12/2025 to 31/05/2027 (18 months) SOFE: (South of England) 01/12/2025 to 31/05/2027 (18 months) MAE: (Midlands and East) 01/12/2025 to 31/05/2027 (18 months) LNW: (London) 01/12/2025 to 31/05/2027 (18 months) Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England Provision of Licensed Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England. To include but not limited to aflibercept, bevacizumab, brolucizumab, intravitreal dexamethasone, intravitreal fluocinolone, faricimab and ranibizumab used in the treatment of; • neovascular (wet) age-related macular degeneration (AMD) • visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO) • proliferative diabetic retinopathy (PDR) • visual impairment due to diabetic macular oedema (DME) • visual impairment due to diabetic macular oedema (DME) who are pseudophakic or who are considered insufficiently responsive to, or unsuitable for non-corticosteroid therapy • vision impairment associated with chronic diabetic macular oedema, (DME) • visual impairment due to myopic choroidal neovascularisation (myopic CNV) • retinopathy of prematurity (ROP) with zone I (stage 1+, 2+, 3 or 3+), zone II (stage 2+ or 3+) or AP-ROP (aggressive posterior ROP) disease • inflammation of the posterior segment of the eye presenting as non-infectious uveitis • prevention of relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye
No lot description published.
No usable CPV category has been published, so a comparable market set cannot yet be built.
No planning milestones published.
No linked framework, prior procurement or reprocurement published.
Diagnostic view. “Not published” means this current release does not provide a value.
| OCID | ocds-h6vhtk-055064 |
|---|---|
| Latest release ID | 062482-2025 |
| Latest release timestamp | Mon Oct 06 2025 11:40:50 GMT+0000 (Coordinated Universal Time) |
| Source | find-a-tender |
| Official notice URL | Not published |
| Tender status | complete |
| Procurement method | open |
| Procurement method details | Open procedure |
| Main procurement category | Not published |
| Above threshold | Not published |
| Legal basis | 2023/54 |
| Tender period: start | Not published |
| Tender period: end | Not published |
| Expression of interest deadline | Not published |
| Enquiry deadline | Not published |
| Award period: start | Not published |
| Award period: end | Not published |
| Submission method details | Not published |
| Submission languages | Not published |
| Electronic catalogue policy | Not published |
| Total tender value | Not published |
| Tender lots in source | 1 |
| Tender items in source | 0 |
| Tender documents in source | 1 |
| Awards in latest release | 2 |
| Contracts in latest release | 2 |
| Parties in latest release | 16 |
| Date | Event | Reference |
|---|---|---|
| 6 Oct 2025 | award, contract | 062482-2025 |
| 1 Aug 2025 | award, contract | 045153-2025 |
Unmodified official OCDS data retained by Tenderline for this procurement process.
{
"id": "062482-2025",
"tag": [
"award",
"contract"
],
"date": "2025-10-06T12:40:50+01:00",
"ocid": "ocds-h6vhtk-055064",
"buyer": {
"id": "GB-PPON-PDPT-3135-BWWY",
"name": "NHS England"
},
"awards": [
{
"id": "2",
"items": [
{
"id": "1",
"relatedLot": "1",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
}
],
"status": "active",
"suppliers": [
{
"id": "GB-PPON-PHRQ-1133-WGCH",
"name": "Abbvie Ltd"
},
{
"id": "GB-PPON-PYCZ-7339-TCCT",
"name": "Alimera Sciences"
},
{
"id": "GB-COH-00935048",
"name": "Bayer Plc"
},
{
"id": "GB-PPON-PTGT-3385-PBMQ",
"name": "Biogen"
},
{
"id": "GB-PPON-PJTX-5182-QVLR",
"name": "Novartis Pharmaceuticals UK Ltd"
},
{
"id": "GB-PPON-PJZQ-1429-ZBVY",
"name": "Orion Pharma (UK) Ltd"
},
{
"id": "GB-PPON-PGZH-1763-NPGX",
"name": "Outlook Therapeutics, Inc."
},
{
"id": "GB-PPON-PXCG-4172-CHYM",
"name": "Roche Products Ltd"
},
{
"id": "GB-PPON-PWDD-6894-DXRM",
"name": "Teva UK Limited"
},
{
"id": "GB-PPON-PWYH-6892-QYNN",
"name": "Thornton and Ross Ltd"
}
],
"relatedLots": [
"1"
],
"mainProcurementCategory": "goods"
},
{
"id": "3",
"items": [
{
"id": "1",
"relatedLot": "1",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
}
],
"status": "active",
"suppliers": [
{
"id": "GB-PPON-PWRY-2527-LDRY",
"name": "Bayer Plc"
},
{
"id": "GB-PPON-PQQC-5869-LMVX",
"name": "BIOSIMILAR COLLABORATIONS IRELAND LIMITED"
},
{
"id": "GB-PPON-PYQL-4248-PXXY",
"name": "Celltrion Healthcare United Kingdom Limited"
},
{
"id": "GB-PPON-PMHC-1596-RTNX",
"name": "MDBIOLOGICS LTD"
},
{
"id": "GB-PPON-PNQL-1548-CYBZ",
"name": "SANDOZ LIMITED"
}
],
"relatedLots": [
"1"
],
"mainProcurementCategory": "goods"
}
],
"tender": {
"id": "C346388",
"lots": [
{
"id": "1",
"status": "complete"
}
],
"title": "NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025",
"status": "complete",
"documents": [
{
"id": "conflictOfInterest",
"description": "Not published",
"documentType": "conflictOfInterest"
}
],
"legalBasis": {
"id": "2023/54",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
"scheme": "UKPGA"
},
"techniques": {
"frameworkAgreement": {
"type": "open",
"method": "withoutReopeningCompetition",
"description": "Please refer to the ITO Documents for the Operation Description.",
"buyerCategories": "Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points",
"buyerLocationRestrictions": [
{
"gazetteer": {
"scheme": "GB-ITL",
"identifiers": [
"UK"
]
}
}
]
},
"hasFrameworkAgreement": true
},
"description": "NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 \nOffer reference number: CM/PHS/25/5728\nPeriod of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.\nPotential periods of call-offs under the framework agreement:\nCM/PHS/25/5728/01 - National Framework for Medical Retinal Vascular Treatments:\n7NAT (National) 01/12/2025 to 31/05/2027 (18 months)\nCM/PHS/25/5728/02 - Regional Framework for Medical Retinal Vascular Treatments aflibercept 2mg:\nNOFE: (North of England) 01/12/2025 to 31/05/2027 (18 months) \nSOFE: (South of England) 01/12/2025 to 31/05/2027 (18 months) \nMAE: (Midlands and East) 01/12/2025 to 31/05/2027 (18 months)\nLNW: (London) 01/12/2025 to 31/05/2027 (18 months)\nPublished By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England \nProvision of Licensed Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England. To include but not limited to aflibercept, bevacizumab, brolucizumab, intravitreal dexamethasone, intravitreal fluocinolone, faricimab and ranibizumab used in the treatment of; \n• neovascular (wet) age-related macular degeneration (AMD)\n• visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO)\n• proliferative diabetic retinopathy (PDR)\n• visual impairment due to diabetic macular oedema (DME) \n• visual impairment due to diabetic macular oedema (DME) who are pseudophakic or who are considered insufficiently responsive to, or unsuitable for non-corticosteroid therapy\n• vision impairment associated with chronic diabetic macular oedema, (DME)\n• visual impairment due to myopic choroidal neovascularisation (myopic CNV) \n• retinopathy of prematurity (ROP) with zone I (stage 1+, 2+, 3 or 3+), zone II (stage 2+ or 3+) or AP-ROP (aggressive posterior ROP) disease\n• inflammation of the posterior segment of the eye presenting as non-infectious uveitis\n• prevention of relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye",
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure"
},
"parties": [
{
"id": "GB-PPON-PDPT-3135-BWWY",
"name": "NHS England",
"roles": [
"buyer"
],
"address": {
"region": "UKI45",
"country": "GB",
"locality": "London",
"postalCode": "SE1 8UG",
"countryName": "United Kingdom",
"streetAddress": "Wellington House, 133-135 Waterloo Rd"
},
"details": {
"url": "https://www.england.nhs.uk/",
"classifications": [
{
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - central government"
}
]
},
"identifier": {
"id": "PDPT-3135-BWWY",
"scheme": "GB-PPON"
},
"contactPoint": {
"name": "Balram Kullootee",
"email": "b.kullootee@nhs.net"
}
},
{
"id": "GB-PPON-PHRQ-1133-WGCH",
"name": "Abbvie Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UKJ11",
"country": "GB",
"locality": "Maidenhead",
"postalCode": "SL6 4UB",
"countryName": "United Kingdom",
"streetAddress": "Abbvie House Vanwall Business Park"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PHRQ-1133-WGCH",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "val.stenning@abbvie.com"
}
},
{
"id": "GB-PPON-PYCZ-7339-TCCT",
"name": "Alimera Sciences",
"roles": [
"supplier"
],
"address": {
"region": "UKJ37",
"country": "GB",
"locality": "Hook",
"postalCode": "RG27 9XA",
"countryName": "United Kingdom",
"streetAddress": "Form 1 Bartley Wood Business Park"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PYCZ-7339-TCCT",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "catherine.griffiths@alimerasciences.com"
}
},
{
"id": "GB-COH-00935048",
"name": "Bayer Plc",
"roles": [
"supplier"
],
"address": {
"region": "UKJ11",
"country": "GB",
"locality": "Reading",
"postalCode": "RG26AD",
"countryName": "United Kingdom",
"streetAddress": "400 South Oak Way"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "00935048",
"scheme": "GB-COH"
},
"contactPoint": {
"email": "andrew.asbury@bayer.com"
}
},
{
"id": "GB-PPON-PTGT-3385-PBMQ",
"name": "Biogen",
"roles": [
"supplier"
],
"address": {
"region": "UKJ11",
"country": "GB",
"locality": "Maidenhead",
"postalCode": "SL63UD",
"countryName": "United Kingdom",
"streetAddress": "Building 5 Foundation Park"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PTGT-3385-PBMQ",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "bbumarketaccessuk@biogen.com"
}
},
{
"id": "GB-PPON-PJTX-5182-QVLR",
"name": "Novartis Pharmaceuticals UK Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UKI33",
"country": "GB",
"locality": "London",
"postalCode": "W12 7FQ",
"countryName": "United Kingdom",
"streetAddress": "2nd Floor, The Westworks Building White City Place"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PJTX-5182-QVLR",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "commercial.team@novartis.com"
}
},
{
"id": "GB-PPON-PJZQ-1429-ZBVY",
"name": "Orion Pharma (UK) Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UKI31",
"country": "GB",
"locality": "London",
"postalCode": "EC3M 7AF",
"countryName": "United Kingdom",
"streetAddress": "The Scalpel, 18th Floor"
},
"details": {
"vcse": false,
"scale": "sme",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PJZQ-1429-ZBVY",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "mark.soderberg@orionpharma.com"
}
},
{
"id": "GB-PPON-PGZH-1763-NPGX",
"name": "Outlook Therapeutics, Inc.",
"roles": [
"supplier"
],
"address": {
"region": "UKJ25",
"country": "GB",
"locality": "Surrey",
"postalCode": "GU1 1UN",
"countryName": "United Kingdom",
"streetAddress": "3rd Floor One London Square, Cross Lanes, Guildford,"
},
"details": {
"vcse": false,
"scale": "sme",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PGZH-1763-NPGX",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "uktenders@outlooktherapeutics.com"
}
},
{
"id": "GB-PPON-PXCG-4172-CHYM",
"name": "Roche Products Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UKH23",
"country": "GB",
"locality": "Welwyn Garden City",
"postalCode": "AL7 1TW",
"countryName": "United Kingdom",
"streetAddress": "6 Falcon Way"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PXCG-4172-CHYM",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "welwyn.rx_bdop@roche.com"
}
},
{
"id": "GB-PPON-PWDD-6894-DXRM",
"name": "Teva UK Limited",
"roles": [
"supplier"
],
"address": {
"region": "UKE45",
"country": "GB",
"locality": "Castleford",
"postalCode": "WF10 5HX",
"countryName": "United Kingdom",
"streetAddress": "Ridings Point"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PWDD-6894-DXRM",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "chrissie.kellett@tevauk.com"
}
},
{
"id": "GB-PPON-PWYH-6892-QYNN",
"name": "Thornton and Ross Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UKE44",
"country": "GB",
"locality": "Huddersfield",
"postalCode": "HD7 5QH",
"countryName": "United Kingdom",
"streetAddress": "Linthwaite Labs Manchester Road"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PWYH-6892-QYNN",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "rachelwright@thorntonross.com"
}
},
{
"id": "GB-PPON-PWRY-2527-LDRY",
"name": "Bayer Plc",
"roles": [
"supplier"
],
"address": {
"region": "UKJ11",
"country": "GB",
"locality": "Reading",
"postalCode": "RG2 6AD",
"countryName": "United Kingdom",
"streetAddress": "400 South Oak Way"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PWRY-2527-LDRY",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "andrew.asbury@bayer.com"
}
},
{
"id": "GB-PPON-PQQC-5869-LMVX",
"name": "BIOSIMILAR COLLABORATIONS IRELAND LIMITED",
"roles": [
"supplier"
],
"address": {
"region": "UKI31",
"country": "GB",
"locality": "London",
"postalCode": "WC2B 5AH",
"countryName": "United Kingdom",
"streetAddress": "Biocon Biologics 16 Great Queen Street"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PQQC-5869-LMVX",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "uk_tenders@biocon.com"
}
},
{
"id": "GB-PPON-PYQL-4248-PXXY",
"name": "Celltrion Healthcare United Kingdom Limited",
"roles": [
"supplier"
],
"address": {
"region": "UKI74",
"country": "GB",
"locality": "Uxbridge",
"postalCode": "UB8 1JG",
"countryName": "United Kingdom",
"streetAddress": "Celltrion Healthcare UK Limited, The Charter Building, Charter Place"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PYQL-4248-PXXY",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "james.potter@celltrionhc.com"
}
},
{
"id": "GB-PPON-PMHC-1596-RTNX",
"name": "MDBIOLOGICS LTD",
"roles": [
"supplier"
],
"address": {
"region": "UKI31",
"country": "GB",
"locality": "London",
"postalCode": "WC2H 9JQ",
"countryName": "United Kingdom",
"streetAddress": "71-75 Shelton Street"
},
"details": {
"vcse": false,
"scale": "sme",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PMHC-1596-RTNX",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "paul.clark@mdbiologics.co.uk"
}
},
{
"id": "GB-PPON-PNQL-1548-CYBZ",
"name": "SANDOZ LIMITED",
"roles": [
"supplier"
],
"address": {
"region": "UKJ11",
"country": "GB",
"locality": "Bracknell",
"postalCode": "RG12 1RF",
"countryName": "United Kingdom",
"streetAddress": "Maxis 1, Western Road"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PNQL-1548-CYBZ",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "uk.hosp@sandoz.com"
}
}
],
"language": "en",
"contracts": [
{
"id": "2",
"title": "Lot 1 - CM/PHS/25/5728/01",
"value": {
"amount": 688834174,
"currency": "GBP",
"amountGross": 826601009
},
"period": {
"endDate": "2027-05-31T23:59:59+01:00",
"startDate": "2025-12-01T00:00:00Z",
"maxExtentDate": "2029-05-31T23:59:59+01:00"
},
"status": "active",
"awardID": "2",
"renewal": {
"description": "option or options to extend (at the discretion of the Authority) up to maximum of 24 months."
},
"documents": [
{
"id": "A-5896",
"url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-5896",
"format": "application/pdf",
"description": "Framework Agreement and Terms and Conditions - Lot 1",
"documentType": "contractSigned"
},
{
"id": "062482-2025",
"url": "https://www.find-tender.service.gov.uk/Notice/062482-2025",
"format": "text/html",
"noticeType": "UK7",
"description": "Contract details notice on Find a Tender",
"documentType": "contractNotice",
"datePublished": "2025-10-06T12:40:50+01:00"
}
],
"dateSigned": "2025-09-22T00:00:00+01:00",
"hasRenewal": true,
"agreedMetrics": [
{
"id": "1",
"title": "Buffer Stock requirement",
"description": "6 months Buffer Stock",
"observations": [
{
"id": "frequency",
"period": {
"durationInMonths": 3
}
}
]
}
],
"aboveThreshold": true
},
{
"id": "3",
"title": "Lot 2 - CM/PHS/25/5728/02",
"value": {
"amount": 782917972,
"currency": "GBP",
"amountGross": 939501566
},
"period": {
"endDate": "2027-05-31T23:59:59+01:00",
"startDate": "2025-12-01T00:00:00Z",
"maxExtentDate": "2029-05-31T23:59:59+01:00"
},
"status": "active",
"awardID": "3",
"renewal": {
"description": "option or options to extend (at the discretion of the Authority) up to maximum of 24 months."
},
"documents": [
{
"id": "A-5897",
"url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-5897",
"format": "application/pdf",
"description": "Framework Agreement and Terms and Conditions - Lot 2",
"documentType": "contractSigned"
},
{
"id": "062482-2025",
"url": "https://www.find-tender.service.gov.uk/Notice/062482-2025",
"format": "text/html",
"noticeType": "UK7",
"description": "Contract details notice on Find a Tender",
"documentType": "contractNotice",
"datePublished": "2025-10-06T12:40:50+01:00"
}
],
"dateSigned": "2025-09-22T00:00:00+01:00",
"hasRenewal": true,
"agreedMetrics": [
{
"id": "1",
"title": "Buffer Stock",
"description": "6 months Buffer Stock",
"observations": [
{
"id": "frequency",
"period": {
"durationInMonths": 3
}
}
]
}
],
"aboveThreshold": true
}
],
"initiationType": "tender"
}{
"id": "062482-2025",
"tag": [
"award",
"contract"
],
"date": "2025-10-06T12:40:50+01:00",
"ocid": "ocds-h6vhtk-055064",
"buyer": {
"id": "GB-PPON-PDPT-3135-BWWY",
"name": "NHS England"
},
"awards": [
{
"id": "2",
"items": [
{
"id": "1",
"relatedLot": "1",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
}
],
"status": "active",
"suppliers": [
{
"id": "GB-PPON-PHRQ-1133-WGCH",
"name": "Abbvie Ltd"
},
{
"id": "GB-PPON-PYCZ-7339-TCCT",
"name": "Alimera Sciences"
},
{
"id": "GB-COH-00935048",
"name": "Bayer Plc"
},
{
"id": "GB-PPON-PTGT-3385-PBMQ",
"name": "Biogen"
},
{
"id": "GB-PPON-PJTX-5182-QVLR",
"name": "Novartis Pharmaceuticals UK Ltd"
},
{
"id": "GB-PPON-PJZQ-1429-ZBVY",
"name": "Orion Pharma (UK) Ltd"
},
{
"id": "GB-PPON-PGZH-1763-NPGX",
"name": "Outlook Therapeutics, Inc."
},
{
"id": "GB-PPON-PXCG-4172-CHYM",
"name": "Roche Products Ltd"
},
{
"id": "GB-PPON-PWDD-6894-DXRM",
"name": "Teva UK Limited"
},
{
"id": "GB-PPON-PWYH-6892-QYNN",
"name": "Thornton and Ross Ltd"
}
],
"relatedLots": [
"1"
],
"mainProcurementCategory": "goods"
},
{
"id": "3",
"items": [
{
"id": "1",
"relatedLot": "1",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
}
],
"status": "active",
"suppliers": [
{
"id": "GB-PPON-PWRY-2527-LDRY",
"name": "Bayer Plc"
},
{
"id": "GB-PPON-PQQC-5869-LMVX",
"name": "BIOSIMILAR COLLABORATIONS IRELAND LIMITED"
},
{
"id": "GB-PPON-PYQL-4248-PXXY",
"name": "Celltrion Healthcare United Kingdom Limited"
},
{
"id": "GB-PPON-PMHC-1596-RTNX",
"name": "MDBIOLOGICS LTD"
},
{
"id": "GB-PPON-PNQL-1548-CYBZ",
"name": "SANDOZ LIMITED"
}
],
"relatedLots": [
"1"
],
"mainProcurementCategory": "goods"
}
],
"tender": {
"id": "C346388",
"lots": [
{
"id": "1",
"status": "complete"
}
],
"title": "NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025",
"status": "complete",
"documents": [
{
"id": "conflictOfInterest",
"description": "Not published",
"documentType": "conflictOfInterest"
}
],
"legalBasis": {
"id": "2023/54",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
"scheme": "UKPGA"
},
"techniques": {
"frameworkAgreement": {
"type": "open",
"method": "withoutReopeningCompetition",
"description": "Please refer to the ITO Documents for the Operation Description.",
"buyerCategories": "Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points",
"buyerLocationRestrictions": [
{
"gazetteer": {
"scheme": "GB-ITL",
"identifiers": [
"UK"
]
}
}
]
},
"hasFrameworkAgreement": true
},
"description": "NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 \nOffer reference number: CM/PHS/25/5728\nPeriod of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.\nPotential periods of call-offs under the framework agreement:\nCM/PHS/25/5728/01 - National Framework for Medical Retinal Vascular Treatments:\n7NAT (National) 01/12/2025 to 31/05/2027 (18 months)\nCM/PHS/25/5728/02 - Regional Framework for Medical Retinal Vascular Treatments aflibercept 2mg:\nNOFE: (North of England) 01/12/2025 to 31/05/2027 (18 months) \nSOFE: (South of England) 01/12/2025 to 31/05/2027 (18 months) \nMAE: (Midlands and East) 01/12/2025 to 31/05/2027 (18 months)\nLNW: (London) 01/12/2025 to 31/05/2027 (18 months)\nPublished By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England \nProvision of Licensed Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England. To include but not limited to aflibercept, bevacizumab, brolucizumab, intravitreal dexamethasone, intravitreal fluocinolone, faricimab and ranibizumab used in the treatment of; \n• neovascular (wet) age-related macular degeneration (AMD)\n• visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO)\n• proliferative diabetic retinopathy (PDR)\n• visual impairment due to diabetic macular oedema (DME) \n• visual impairment due to diabetic macular oedema (DME) who are pseudophakic or who are considered insufficiently responsive to, or unsuitable for non-corticosteroid therapy\n• vision impairment associated with chronic diabetic macular oedema, (DME)\n• visual impairment due to myopic choroidal neovascularisation (myopic CNV) \n• retinopathy of prematurity (ROP) with zone I (stage 1+, 2+, 3 or 3+), zone II (stage 2+ or 3+) or AP-ROP (aggressive posterior ROP) disease\n• inflammation of the posterior segment of the eye presenting as non-infectious uveitis\n• prevention of relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye",
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure"
},
"parties": [
{
"id": "GB-PPON-PDPT-3135-BWWY",
"name": "NHS England",
"roles": [
"buyer"
],
"address": {
"region": "UKI45",
"country": "GB",
"locality": "London",
"postalCode": "SE1 8UG",
"countryName": "United Kingdom",
"streetAddress": "Wellington House, 133-135 Waterloo Rd"
},
"details": {
"url": "https://www.england.nhs.uk/",
"classifications": [
{
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - central government"
}
]
},
"identifier": {
"id": "PDPT-3135-BWWY",
"scheme": "GB-PPON"
},
"contactPoint": {
"name": "Balram Kullootee",
"email": "b.kullootee@nhs.net"
}
},
{
"id": "GB-PPON-PHRQ-1133-WGCH",
"name": "Abbvie Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UKJ11",
"country": "GB",
"locality": "Maidenhead",
"postalCode": "SL6 4UB",
"countryName": "United Kingdom",
"streetAddress": "Abbvie House Vanwall Business Park"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PHRQ-1133-WGCH",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "val.stenning@abbvie.com"
}
},
{
"id": "GB-PPON-PYCZ-7339-TCCT",
"name": "Alimera Sciences",
"roles": [
"supplier"
],
"address": {
"region": "UKJ37",
"country": "GB",
"locality": "Hook",
"postalCode": "RG27 9XA",
"countryName": "United Kingdom",
"streetAddress": "Form 1 Bartley Wood Business Park"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PYCZ-7339-TCCT",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "catherine.griffiths@alimerasciences.com"
}
},
{
"id": "GB-COH-00935048",
"name": "Bayer Plc",
"roles": [
"supplier"
],
"address": {
"region": "UKJ11",
"country": "GB",
"locality": "Reading",
"postalCode": "RG26AD",
"countryName": "United Kingdom",
"streetAddress": "400 South Oak Way"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "00935048",
"scheme": "GB-COH"
},
"contactPoint": {
"email": "andrew.asbury@bayer.com"
}
},
{
"id": "GB-PPON-PTGT-3385-PBMQ",
"name": "Biogen",
"roles": [
"supplier"
],
"address": {
"region": "UKJ11",
"country": "GB",
"locality": "Maidenhead",
"postalCode": "SL63UD",
"countryName": "United Kingdom",
"streetAddress": "Building 5 Foundation Park"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PTGT-3385-PBMQ",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "bbumarketaccessuk@biogen.com"
}
},
{
"id": "GB-PPON-PJTX-5182-QVLR",
"name": "Novartis Pharmaceuticals UK Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UKI33",
"country": "GB",
"locality": "London",
"postalCode": "W12 7FQ",
"countryName": "United Kingdom",
"streetAddress": "2nd Floor, The Westworks Building White City Place"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PJTX-5182-QVLR",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "commercial.team@novartis.com"
}
},
{
"id": "GB-PPON-PJZQ-1429-ZBVY",
"name": "Orion Pharma (UK) Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UKI31",
"country": "GB",
"locality": "London",
"postalCode": "EC3M 7AF",
"countryName": "United Kingdom",
"streetAddress": "The Scalpel, 18th Floor"
},
"details": {
"vcse": false,
"scale": "sme",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PJZQ-1429-ZBVY",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "mark.soderberg@orionpharma.com"
}
},
{
"id": "GB-PPON-PGZH-1763-NPGX",
"name": "Outlook Therapeutics, Inc.",
"roles": [
"supplier"
],
"address": {
"region": "UKJ25",
"country": "GB",
"locality": "Surrey",
"postalCode": "GU1 1UN",
"countryName": "United Kingdom",
"streetAddress": "3rd Floor One London Square, Cross Lanes, Guildford,"
},
"details": {
"vcse": false,
"scale": "sme",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PGZH-1763-NPGX",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "uktenders@outlooktherapeutics.com"
}
},
{
"id": "GB-PPON-PXCG-4172-CHYM",
"name": "Roche Products Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UKH23",
"country": "GB",
"locality": "Welwyn Garden City",
"postalCode": "AL7 1TW",
"countryName": "United Kingdom",
"streetAddress": "6 Falcon Way"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PXCG-4172-CHYM",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "welwyn.rx_bdop@roche.com"
}
},
{
"id": "GB-PPON-PWDD-6894-DXRM",
"name": "Teva UK Limited",
"roles": [
"supplier"
],
"address": {
"region": "UKE45",
"country": "GB",
"locality": "Castleford",
"postalCode": "WF10 5HX",
"countryName": "United Kingdom",
"streetAddress": "Ridings Point"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PWDD-6894-DXRM",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "chrissie.kellett@tevauk.com"
}
},
{
"id": "GB-PPON-PWYH-6892-QYNN",
"name": "Thornton and Ross Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UKE44",
"country": "GB",
"locality": "Huddersfield",
"postalCode": "HD7 5QH",
"countryName": "United Kingdom",
"streetAddress": "Linthwaite Labs Manchester Road"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PWYH-6892-QYNN",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "rachelwright@thorntonross.com"
}
},
{
"id": "GB-PPON-PWRY-2527-LDRY",
"name": "Bayer Plc",
"roles": [
"supplier"
],
"address": {
"region": "UKJ11",
"country": "GB",
"locality": "Reading",
"postalCode": "RG2 6AD",
"countryName": "United Kingdom",
"streetAddress": "400 South Oak Way"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PWRY-2527-LDRY",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "andrew.asbury@bayer.com"
}
},
{
"id": "GB-PPON-PQQC-5869-LMVX",
"name": "BIOSIMILAR COLLABORATIONS IRELAND LIMITED",
"roles": [
"supplier"
],
"address": {
"region": "UKI31",
"country": "GB",
"locality": "London",
"postalCode": "WC2B 5AH",
"countryName": "United Kingdom",
"streetAddress": "Biocon Biologics 16 Great Queen Street"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PQQC-5869-LMVX",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "uk_tenders@biocon.com"
}
},
{
"id": "GB-PPON-PYQL-4248-PXXY",
"name": "Celltrion Healthcare United Kingdom Limited",
"roles": [
"supplier"
],
"address": {
"region": "UKI74",
"country": "GB",
"locality": "Uxbridge",
"postalCode": "UB8 1JG",
"countryName": "United Kingdom",
"streetAddress": "Celltrion Healthcare UK Limited, The Charter Building, Charter Place"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PYQL-4248-PXXY",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "james.potter@celltrionhc.com"
}
},
{
"id": "GB-PPON-PMHC-1596-RTNX",
"name": "MDBIOLOGICS LTD",
"roles": [
"supplier"
],
"address": {
"region": "UKI31",
"country": "GB",
"locality": "London",
"postalCode": "WC2H 9JQ",
"countryName": "United Kingdom",
"streetAddress": "71-75 Shelton Street"
},
"details": {
"vcse": false,
"scale": "sme",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PMHC-1596-RTNX",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "paul.clark@mdbiologics.co.uk"
}
},
{
"id": "GB-PPON-PNQL-1548-CYBZ",
"name": "SANDOZ LIMITED",
"roles": [
"supplier"
],
"address": {
"region": "UKJ11",
"country": "GB",
"locality": "Bracknell",
"postalCode": "RG12 1RF",
"countryName": "United Kingdom",
"streetAddress": "Maxis 1, Western Road"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PNQL-1548-CYBZ",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "uk.hosp@sandoz.com"
}
}
],
"language": "en",
"contracts": [
{
"id": "2",
"title": "Lot 1 - CM/PHS/25/5728/01",
"value": {
"amount": 688834174,
"currency": "GBP",
"amountGross": 826601009
},
"period": {
"endDate": "2027-05-31T23:59:59+01:00",
"startDate": "2025-12-01T00:00:00Z",
"maxExtentDate": "2029-05-31T23:59:59+01:00"
},
"status": "active",
"awardID": "2",
"renewal": {
"description": "option or options to extend (at the discretion of the Authority) up to maximum of 24 months."
},
"documents": [
{
"id": "A-5896",
"url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-5896",
"format": "application/pdf",
"description": "Framework Agreement and Terms and Conditions - Lot 1",
"documentType": "contractSigned"
},
{
"id": "062482-2025",
"url": "https://www.find-tender.service.gov.uk/Notice/062482-2025",
"format": "text/html",
"noticeType": "UK7",
"description": "Contract details notice on Find a Tender",
"documentType": "contractNotice",
"datePublished": "2025-10-06T12:40:50+01:00"
}
],
"dateSigned": "2025-09-22T00:00:00+01:00",
"hasRenewal": true,
"agreedMetrics": [
{
"id": "1",
"title": "Buffer Stock requirement",
"description": "6 months Buffer Stock",
"observations": [
{
"id": "frequency",
"period": {
"durationInMonths": 3
}
}
]
}
],
"aboveThreshold": true
},
{
"id": "3",
"title": "Lot 2 - CM/PHS/25/5728/02",
"value": {
"amount": 782917972,
"currency": "GBP",
"amountGross": 939501566
},
"period": {
"endDate": "2027-05-31T23:59:59+01:00",
"startDate": "2025-12-01T00:00:00Z",
"maxExtentDate": "2029-05-31T23:59:59+01:00"
},
"status": "active",
"awardID": "3",
"renewal": {
"description": "option or options to extend (at the discretion of the Authority) up to maximum of 24 months."
},
"documents": [
{
"id": "A-5897",
"url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-5897",
"format": "application/pdf",
"description": "Framework Agreement and Terms and Conditions - Lot 2",
"documentType": "contractSigned"
},
{
"id": "062482-2025",
"url": "https://www.find-tender.service.gov.uk/Notice/062482-2025",
"format": "text/html",
"noticeType": "UK7",
"description": "Contract details notice on Find a Tender",
"documentType": "contractNotice",
"datePublished": "2025-10-06T12:40:50+01:00"
}
],
"dateSigned": "2025-09-22T00:00:00+01:00",
"hasRenewal": true,
"agreedMetrics": [
{
"id": "1",
"title": "Buffer Stock",
"description": "6 months Buffer Stock",
"observations": [
{
"id": "frequency",
"period": {
"durationInMonths": 3
}
}
]
}
],
"aboveThreshold": true
}
],
"initiationType": "tender"
}{
"id": "045153-2025",
"tag": [
"award",
"contract"
],
"bids": {
"details": [
{
"id": "1",
"status": "valid",
"tenderers": [
{
"id": "GB-COH-08004972",
"name": "ABBVIE LTD"
}
],
"relatedLots": [
"1"
]
},
{
"id": "2",
"status": "valid",
"tenderers": [
{
"id": "GB-COH-08018355",
"name": "ALIMERA SCIENCES LIMITED"
}
],
"relatedLots": [
"1"
]
},
{
"id": "3",
"status": "valid",
"tenderers": [
{
"id": "GB-COH-01497267",
"name": "BIOGEN IDEC LIMITED"
}
],
"relatedLots": [
"1"
]
},
{
"id": "4",
"status": "valid",
"tenderers": [
{
"id": "GB-COH-00100674",
"name": "ROCHE PRODUCTS LIMITED"
}
],
"relatedLots": [
"1"
]
},
{
"id": "5",
"status": "valid",
"tenderers": [
{
"id": "GB-COH-00119006",
"name": "NOVARTIS PHARMACEUTICALS UK LIMITED"
}
],
"relatedLots": [
"1"
]
},
{
"id": "6",
"status": "valid",
"tenderers": [
{
"id": "GB-COH-02281057",
"name": "ORION PHARMA (UK) LIMITED"
}
],
"relatedLots": [
"1"
]
},
{
"id": "7",
"status": "valid",
"tenderers": [
{
"id": "GB-COH-08179857",
"name": "Outlook Therapeutics, Inc."
}
],
"relatedLots": [
"1"
]
},
{
"id": "8",
"status": "valid",
"tenderers": [
{
"id": "GB-COH-00302461",
"name": "TEVA UK LIMITED"
}
],
"relatedLots": [
"1"
]
},
{
"id": "9",
"status": "valid",
"tenderers": [
{
"id": "GB-COH-00185947",
"name": "THORNTON & ROSS LIMITED"
}
],
"relatedLots": [
"1"
]
},
{
"id": "10",
"status": "valid",
"tenderers": [
{
"id": "GB-COH-00935048",
"name": "BAYER PUBLIC LIMITED COMPANY"
}
],
"relatedLots": [
"1",
"2"
]
},
{
"id": "11",
"status": "valid",
"tenderers": [
{
"id": "GB-PPON-PQQC-5869-LMVX",
"name": "Biosimilar Collaborations Ireland Limited"
}
],
"relatedLots": [
"2"
]
},
{
"id": "12",
"status": "valid",
"tenderers": [
{
"id": "GB-COH-11685363",
"name": "CELLTRION HEALTHCARE UNITED KINGDOM LIMITED"
}
],
"relatedLots": [
"2"
]
},
{
"id": "13",
"status": "valid",
"tenderers": [
{
"id": "GB-COH-15579040",
"name": "MDBIOLOGICS LTD"
}
],
"relatedLots": [
"2"
]
},
{
"id": "14",
"status": "valid",
"tenderers": [
{
"id": "GB-COH-01547204",
"name": "SANDOZ LIMITED"
}
],
"relatedLots": [
"2"
]
},
{
"id": "15",
"status": "valid",
"tenderers": [
{
"id": "GB-COH-10015046",
"name": "ORIFARM UK LTD"
}
],
"relatedLots": [
"1"
]
},
{
"id": "16",
"status": "valid",
"tenderers": [
{
"id": "GB-COH-02619880",
"name": "MERCURY PHARMACEUTICALS LIMITED"
}
],
"relatedLots": [
"2"
]
},
{
"id": "17",
"status": "valid",
"tenderers": [
{
"id": "GB-COH-02354269",
"name": "AMGEN LIMITED"
}
],
"relatedLots": [
"2"
]
}
],
"statistics": [
{
"id": "1",
"value": 11,
"measure": "bids",
"relatedLot": "1"
},
{
"id": "2",
"value": 7,
"measure": "bids",
"relatedLot": "2"
},
{
"id": "3",
"value": 11,
"measure": "finalStageBids",
"relatedLot": "1"
},
{
"id": "4",
"value": 4,
"measure": "smeFinalStageBids",
"relatedLot": "1"
},
{
"id": "5",
"value": 0,
"measure": "vcseFinalStageBids",
"relatedLot": "1"
},
{
"id": "6",
"value": 7,
"measure": "finalStageBids",
"relatedLot": "2"
},
{
"id": "7",
"value": 1,
"measure": "smeFinalStageBids",
"relatedLot": "2"
},
{
"id": "8",
"value": 0,
"measure": "vcseFinalStageBids",
"relatedLot": "2"
}
]
},
"date": "2025-08-01T11:49:34+01:00",
"ocid": "ocds-h6vhtk-055064",
"buyer": {
"id": "GB-NHS-X24",
"name": "NHS ENGLAND"
},
"awards": [
{
"id": "1",
"date": "2025-07-31T00:00:00+01:00",
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryAddresses": [
{
"region": "UKC",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKD",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKE",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKF",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKG",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKH",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKI",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKJ",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKK",
"country": "GB",
"countryName": "United Kingdom"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
}
],
"title": "Lot 1 - CM/PHS/25/5728/01",
"value": {
"amount": 688834174,
"currency": "GBP",
"amountGross": 826601009
},
"status": "pending",
"renewal": {
"description": "option or options to extend (at the discretion of the Authority) up to maximum of 24 months."
},
"documents": [
{
"id": "045153-2025",
"url": "https://www.find-tender.service.gov.uk/Notice/045153-2025",
"format": "text/html",
"noticeType": "UK6",
"description": "Contract award notice on Find a Tender",
"documentType": "awardNotice",
"datePublished": "2025-08-01T11:49:34+01:00"
}
],
"suppliers": [
{
"id": "GB-COH-08004972",
"name": "ABBVIE LTD"
},
{
"id": "GB-COH-08018355",
"name": "ALIMERA SCIENCES LIMITED"
},
{
"id": "GB-COH-01497267",
"name": "BIOGEN IDEC LIMITED"
},
{
"id": "GB-COH-00100674",
"name": "ROCHE PRODUCTS LIMITED"
},
{
"id": "GB-COH-00119006",
"name": "NOVARTIS PHARMACEUTICALS UK LIMITED"
},
{
"id": "GB-COH-02281057",
"name": "ORION PHARMA (UK) LIMITED"
},
{
"id": "GB-COH-08179857",
"name": "Outlook Therapeutics, Inc."
},
{
"id": "GB-COH-00302461",
"name": "TEVA UK LIMITED"
},
{
"id": "GB-COH-00185947",
"name": "THORNTON & ROSS LIMITED"
},
{
"id": "GB-COH-00935048",
"name": "BAYER PUBLIC LIMITED COMPANY"
}
],
"hasRenewal": true,
"milestones": [
{
"id": "1",
"type": "futureSignatureDate",
"status": "scheduled",
"dueDate": "2025-08-18T23:59:59+01:00"
}
],
"relatedLots": [
"1"
],
"aboveThreshold": true,
"contractPeriod": {
"endDate": "2027-05-31T23:59:59+01:00",
"startDate": "2025-12-01T00:00:00Z",
"maxExtentDate": "2029-05-31T23:59:59+01:00"
},
"standstillPeriod": {
"endDate": "2025-08-13T23:59:59+01:00"
},
"mainProcurementCategory": "goods",
"assessmentSummariesDateSent": "2025-07-31T00:00:00+01:00"
},
{
"id": "2",
"date": "2025-07-31T00:00:00+01:00",
"items": [
{
"id": "2",
"relatedLot": "2",
"deliveryAddresses": [
{
"region": "UKC",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKD",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKE",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKF",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKG",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKH",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKI",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKJ",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKK",
"country": "GB",
"countryName": "United Kingdom"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
}
],
"title": "Lot 2 - CM/PHS/25/5728/02",
"value": {
"amount": 782917972,
"currency": "GBP",
"amountGross": 939501566
},
"status": "pending",
"renewal": {
"description": "option or options to extend (at the discretion of the Authority) up to maximum of 24 months."
},
"documents": [
{
"id": "045153-2025",
"url": "https://www.find-tender.service.gov.uk/Notice/045153-2025",
"format": "text/html",
"noticeType": "UK6",
"description": "Contract award notice on Find a Tender",
"documentType": "awardNotice",
"datePublished": "2025-08-01T11:49:34+01:00"
}
],
"suppliers": [
{
"id": "GB-PPON-PQQC-5869-LMVX",
"name": "Biosimilar Collaborations Ireland Limited"
},
{
"id": "GB-COH-11685363",
"name": "CELLTRION HEALTHCARE UNITED KINGDOM LIMITED"
},
{
"id": "GB-COH-15579040",
"name": "MDBIOLOGICS LTD"
},
{
"id": "GB-COH-01547204",
"name": "SANDOZ LIMITED"
},
{
"id": "GB-COH-00935048",
"name": "BAYER PUBLIC LIMITED COMPANY"
}
],
"hasRenewal": true,
"milestones": [
{
"id": "1",
"type": "futureSignatureDate",
"status": "scheduled",
"dueDate": "2025-08-18T23:59:59+01:00"
}
],
"relatedLots": [
"2"
],
"aboveThreshold": true,
"contractPeriod": {
"endDate": "2027-05-31T23:59:59+01:00",
"startDate": "2025-12-01T00:00:00Z",
"maxExtentDate": "2029-05-31T23:59:59+01:00"
},
"standstillPeriod": {
"endDate": "2025-08-13T23:59:59+01:00"
},
"mainProcurementCategory": "goods",
"assessmentSummariesDateSent": "2025-07-31T00:00:00+01:00"
}
],
"tender": {
"id": "C346388",
"lots": [
{
"id": "1",
"status": "complete"
},
{
"id": "2",
"status": "complete"
}
],
"title": "NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025",
"status": "complete",
"legalBasis": {
"id": "2023/54",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
"scheme": "UKPGA"
},
"techniques": {
"hasFrameworkAgreement": true
},
"description": "NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 \nOffer reference number: CM/PHS/25/5728\nPeriod of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.\nPotential periods of call-offs under the framework agreement:\nCM/PHS/25/5728/01 - National Framework for Medical Retinal Vascular Treatments:\n7NAT (National) 01/12/2025 to 31/05/2027 (18 months)\nCM/PHS/25/5728/02 - Regional Framework for Medical Retinal Vascular Treatments aflibercept 2mg:\nNOFE: (North of England) 01/12/2025 to 31/05/2027 (18 months) \nSOFE: (South of England) 01/12/2025 to 31/05/2027 (18 months) \nMAE: (Midlands and East) 01/12/2025 to 31/05/2027 (18 months)\nLNW: (London) 01/12/2025 to 31/05/2027 (18 months)\nPublished By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England\t\nProvision of Licensed Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England. To include but not limited to aflibercept, bevacizumab, brolucizumab, intravitreal dexamethasone, intravitreal fluocinolone, faricimab and ranibizumab used in the treatment of; \n• neovascular (wet) age-related macular degeneration (AMD)\n• visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO)\n• proliferative diabetic retinopathy (PDR)\n• visual impairment due to diabetic macular oedema (DME) \n• visual impairment due to diabetic macular oedema (DME) who are pseudophakic or who are considered insufficiently responsive to, or unsuitable for non-corticosteroid therapy\n• vision impairment associated with chronic diabetic macular oedema, (DME)\n• visual impairment due to myopic choroidal neovascularisation (myopic CNV) \n• retinopathy of prematurity (ROP) with zone I (stage 1+, 2+, 3 or 3+), zone II (stage 2+ or 3+) or AP-ROP (aggressive posterior ROP) disease\n• inflammation of the posterior segment of the eye presenting as non-infectious uveitis\n• prevention of relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye",
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure"
},
"parties": [
{
"id": "GB-NHS-X24",
"name": "NHS ENGLAND",
"roles": [
"buyer"
],
"address": {
"region": "UKE42",
"country": "GB",
"locality": "Leeds",
"postalCode": "LS1 4AP",
"countryName": "United Kingdom",
"streetAddress": "NHS England, 7&8 Wellington Place"
},
"details": {
"classifications": [
{
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - central government"
}
]
},
"identifier": {
"id": "X24",
"scheme": "GB-NHS"
},
"contactPoint": {
"name": "Balram Kullootee",
"email": "b.kullootee@nhs.net"
},
"additionalIdentifiers": [
{
"id": "PDPT-3135-BWWY",
"scheme": "GB-PPON"
}
]
},
{
"id": "GB-COH-10015046",
"name": "ORIFARM UK LTD",
"roles": [
"tenderer"
],
"address": {
"region": "UKH23",
"country": "GB",
"locality": "Hemel Hempstead",
"postalCode": "HP2 4TZ",
"countryName": "United Kingdom",
"streetAddress": "Ground Floor, Suite A2 Breakspear Way"
},
"details": {
"url": "http://www.orifarm.com",
"vcse": false,
"scale": "sme"
},
"identifier": {
"id": "10015046",
"scheme": "GB-COH"
},
"additionalIdentifiers": [
{
"id": "PQPW-1715-PJLT",
"scheme": "GB-PPON"
}
]
},
{
"id": "GB-COH-02619880",
"name": "MERCURY PHARMACEUTICALS LIMITED",
"roles": [
"tenderer"
],
"address": {
"region": "UKI31",
"country": "GB",
"locality": "London",
"postalCode": "EC2M 1QS",
"countryName": "United Kingdom",
"streetAddress": "Dashwood House"
},
"details": {
"url": "http://www.advanzpharma.com",
"vcse": false,
"scale": "large"
},
"identifier": {
"id": "02619880",
"scheme": "GB-COH"
},
"additionalIdentifiers": [
{
"id": "PHGH-5788-VVDL",
"scheme": "GB-PPON"
}
]
},
{
"id": "GB-COH-02354269",
"name": "AMGEN LIMITED",
"roles": [
"tenderer"
],
"address": {
"region": "UKH12",
"country": "GB",
"locality": "Cambridge",
"postalCode": "CB4 0WA",
"countryName": "United Kingdom",
"streetAddress": "216 Cambridge Science Park"
},
"details": {
"url": "http://www.amgen.co.uk",
"vcse": false,
"scale": "large"
},
"identifier": {
"id": "02354269",
"scheme": "GB-COH"
},
"additionalIdentifiers": [
{
"id": "PDJG-8184-TCQQ",
"scheme": "GB-PPON"
}
]
},
{
"id": "GB-COH-08004972",
"name": "ABBVIE LTD",
"roles": [
"supplier",
"tenderer"
],
"address": {
"region": "UKJ11",
"country": "GB",
"locality": "Maidenhead",
"postalCode": "SL6 4UB",
"countryName": "United Kingdom",
"streetAddress": "Abbvie House Vanwall Business Park"
},
"details": {
"url": "http://www.abbvie.co.uk/",
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "08004972",
"scheme": "GB-COH"
},
"contactPoint": {
"email": "carol.woodland@abbvie.com"
},
"additionalIdentifiers": [
{
"id": "PHRQ-1133-WGCH",
"scheme": "GB-PPON"
}
]
},
{
"id": "GB-COH-08018355",
"name": "ALIMERA SCIENCES LIMITED",
"roles": [
"supplier",
"tenderer"
],
"address": {
"region": "UKJ37",
"country": "GB",
"locality": "Hook",
"postalCode": "RG27 9XA",
"countryName": "United Kingdom",
"streetAddress": "Form 1 Bartley Wood Business Park"
},
"details": {
"url": "http://www.alimerasciences.eu",
"vcse": false,
"scale": "sme",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "08018355",
"scheme": "GB-COH"
},
"contactPoint": {
"email": "catherine.griffiths@alimerasciences.com"
},
"additionalIdentifiers": [
{
"id": "PYCZ-7339-TCCT",
"scheme": "GB-PPON"
}
]
},
{
"id": "GB-COH-01497267",
"name": "BIOGEN IDEC LIMITED",
"roles": [
"supplier",
"tenderer"
],
"address": {
"region": "UKJ11",
"country": "GB",
"locality": "Maidenhead",
"postalCode": "SL6 3UD",
"countryName": "United Kingdom",
"streetAddress": "Building 5 Foundation Park"
},
"details": {
"url": "https://www.biogen-uk-ie.com",
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "01497267",
"scheme": "GB-COH"
},
"contactPoint": {
"email": "bbumarketaccessuk@biogen.com"
},
"additionalIdentifiers": [
{
"id": "PTGT-3385-PBMQ",
"scheme": "GB-PPON"
}
]
},
{
"id": "GB-COH-00100674",
"name": "ROCHE PRODUCTS LIMITED",
"roles": [
"supplier",
"tenderer"
],
"address": {
"region": "UKH23",
"country": "GB",
"locality": "Welwyn Garden City",
"postalCode": "AL7 1TW",
"countryName": "United Kingdom",
"streetAddress": "6 Falcon Way"
},
"details": {
"url": "https://www.roche.co.uk/",
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "00100674",
"scheme": "GB-COH"
},
"contactPoint": {
"email": "welwyn.rx_bdop@roche.com"
},
"additionalIdentifiers": [
{
"id": "PXCG-4172-CHYM",
"scheme": "GB-PPON"
}
]
},
{
"id": "GB-COH-00119006",
"name": "NOVARTIS PHARMACEUTICALS UK LIMITED",
"roles": [
"supplier",
"tenderer"
],
"address": {
"region": "UKI33",
"country": "GB",
"locality": "London",
"postalCode": "W12 7FQ",
"countryName": "United Kingdom",
"streetAddress": "2nd Floor, The Westworks Building White City Place"
},
"details": {
"url": "https://www.novartis.com/uk-en/",
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "00119006",
"scheme": "GB-COH"
},
"contactPoint": {
"email": "commercial.pricing@novartis.com"
},
"additionalIdentifiers": [
{
"id": "PJTX-5182-QVLR",
"scheme": "GB-PPON"
}
]
},
{
"id": "GB-COH-02281057",
"name": "ORION PHARMA (UK) LIMITED",
"roles": [
"supplier",
"tenderer"
],
"address": {
"region": "UKI31",
"country": "GB",
"locality": "London",
"postalCode": "EC3M 7AF",
"countryName": "United Kingdom",
"streetAddress": "The Scalpel, 18th Floor"
},
"details": {
"url": "http://www.orionpharma.co.uk",
"vcse": false,
"scale": "sme",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "02281057",
"scheme": "GB-COH"
},
"contactPoint": {
"email": "mark.soderberg@orionpharma.com"
},
"additionalIdentifiers": [
{
"id": "PJZQ-1429-ZBVY",
"scheme": "GB-PPON"
}
]
},
{
"id": "GB-COH-08179857",
"name": "Outlook Therapeutics, Inc.",
"roles": [
"supplier",
"tenderer"
],
"address": {
"region": "US",
"country": "US",
"locality": "#100 Iselin",
"postalCode": "NJ 08830",
"countryName": "United States",
"streetAddress": "111 S. Wood Ave Unit"
},
"details": {
"url": "https://outlooktherapeutics.com/",
"vcse": false,
"scale": "sme",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "08179857",
"scheme": "GB-COH"
},
"contactPoint": {
"email": "uktenders@OutlookTherapeutics.com"
},
"additionalIdentifiers": [
{
"id": "PGZH-1763-NPGX",
"scheme": "GB-PPON"
}
]
},
{
"id": "GB-COH-00302461",
"name": "TEVA UK LIMITED",
"roles": [
"supplier",
"tenderer"
],
"address": {
"region": "UKE45",
"country": "GB",
"locality": "Castleford",
"postalCode": "WF10 5HX",
"countryName": "United Kingdom",
"streetAddress": "Ridings Point"
},
"details": {
"url": "http://www.tevauk.com",
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "00302461",
"scheme": "GB-COH"
},
"contactPoint": {
"email": "chrissie.kellett@tevauk.com"
},
"additionalIdentifiers": [
{
"id": "PWDD-6894-DXRM",
"scheme": "GB-PPON"
}
]
},
{
"id": "GB-COH-00185947",
"name": "THORNTON & ROSS LIMITED",
"roles": [
"supplier",
"tenderer"
],
"address": {
"region": "UKE44",
"country": "GB",
"locality": "Huddersfield",
"postalCode": "HD7 5QH",
"countryName": "United Kingdom",
"streetAddress": "Linthwaite Labs Manchester Road"
},
"details": {
"url": "https://www.thorntonross.com/",
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "00185947",
"scheme": "GB-COH"
},
"contactPoint": {
"email": "hospitalcontracts@throntonross.com"
},
"additionalIdentifiers": [
{
"id": "PWYH-6892-QYNN",
"scheme": "GB-PPON"
}
]
},
{
"id": "GB-COH-00935048",
"name": "BAYER PUBLIC LIMITED COMPANY",
"roles": [
"supplier",
"tenderer"
],
"address": {
"region": "UKJ11",
"country": "GB",
"locality": "Reading",
"postalCode": "RG2 6AD",
"countryName": "United Kingdom",
"streetAddress": "400 South Oak Way"
},
"details": {
"url": "http://www.bayer.co.uk",
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "00935048",
"scheme": "GB-COH"
},
"contactPoint": {
"email": "andrew.asbury@bayer.com"
},
"additionalIdentifiers": [
{
"id": "PWRY-2527-LDRY",
"scheme": "GB-PPON"
}
]
},
{
"id": "GB-PPON-PQQC-5869-LMVX",
"name": "Biosimilar Collaborations Ireland Limited",
"roles": [
"supplier",
"tenderer"
],
"address": {
"region": "IE",
"country": "IE",
"locality": "DUBLIN",
"postalCode": "D13 R20R",
"countryName": "Ireland",
"streetAddress": "Unit 35/36 Grange Parade, Baldoyle Industrial Estate, Dublin 13"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PQQC-5869-LMVX",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "uk_tenders@biocon.com"
}
},
{
"id": "GB-COH-11685363",
"name": "CELLTRION HEALTHCARE UNITED KINGDOM LIMITED",
"roles": [
"supplier",
"tenderer"
],
"address": {
"region": "UKI74",
"country": "GB",
"locality": "Uxbridge",
"postalCode": "UB8 1JG",
"countryName": "United Kingdom",
"streetAddress": "The Charter Building"
},
"details": {
"url": "https://www.celltrionhealthcare.co.uk",
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "11685363",
"scheme": "GB-COH"
},
"contactPoint": {
"email": "info@celltrionhc.com"
},
"additionalIdentifiers": [
{
"id": "PYQL-4248-PXXY",
"scheme": "GB-PPON"
}
]
},
{
"id": "GB-COH-15579040",
"name": "MDBIOLOGICS LTD",
"roles": [
"supplier",
"tenderer"
],
"address": {
"region": "UKI31",
"country": "GB",
"locality": "London",
"postalCode": "WC2H 9JQ",
"countryName": "United Kingdom",
"streetAddress": "71-75 Shelton Street"
},
"details": {
"url": "http://www.mdbiologics.co.uk",
"vcse": false,
"scale": "sme",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "15579040",
"scheme": "GB-COH"
},
"contactPoint": {
"email": "paul.clark@mdbiologics.co.uk"
},
"additionalIdentifiers": [
{
"id": "PMHC-1596-RTNX",
"scheme": "GB-PPON"
}
]
},
{
"id": "GB-COH-01547204",
"name": "SANDOZ LIMITED",
"roles": [
"supplier",
"tenderer"
],
"address": {
"region": "UKJ11",
"country": "GB",
"locality": "Bracknell",
"postalCode": "RG12 1RF",
"countryName": "United Kingdom",
"streetAddress": "Maxis 1, Western Road"
},
"details": {
"url": "http://www.sandoz.com",
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "01547204",
"scheme": "GB-COH"
},
"contactPoint": {
"email": "uk.tenders@sandoz.com"
},
"additionalIdentifiers": [
{
"id": "PNQL-1548-CYBZ",
"scheme": "GB-PPON"
}
]
}
],
"language": "en",
"initiationType": "tender"
}